D-Wave Quantum stock pops today as QBTS outperforms on year-end options buzz
30 December 2025
1 min read

D-Wave Quantum stock pops today as QBTS outperforms on year-end options buzz

NEW YORK, December 30, 2025, 1:03 PM ET — Regular session

  • D-Wave Quantum shares rose about 2.6% to $26.82, outpacing a slightly lower broader market. 1
  • Quantum “pure-play” peers IonQ, Rigetti and Quantum Computing also traded higher in the regular session.
  • Traders are watching options-implied volatility and the company’s January CES Foundry appearance for any commercial updates. 2

D-Wave Quantum Inc. shares climbed on Tuesday, extending a choppy year-end stretch for quantum-computing stocks as the group again outperformed a flat-to-weaker U.S. market. 1

The move matters because quantum names have become a high-beta pocket of the tech market, with swings amplified by thin holiday liquidity and active retail trading. Investors.com said the group saw a late-December pop followed by profit-taking in the sessions that followed. 3

D-Wave has been one of the sector’s standout gainers in 2025, but the stock remains well off its highs, underscoring how quickly sentiment can shift heading into 2026. 3

Shares of the Palo Alto, California-based company were up 2.6% at $26.82 in afternoon trading, after closing Monday at $26.15. 3

The broader backdrop was subdued: the S&P 500 and Nasdaq were both down about 0.06% on the session, while the Dow was off about 0.15%. 1

The rally in QBTS came alongside gains in other quantum-computing stocks, with IonQ up about 2%, Rigetti up about 1% and Quantum Computing up about 1% in the regular session.

Company news has been sparse in the past week; D-Wave’s most recent press release was on Dec. 22, when it said it will sponsor the CES Foundry in Las Vegas on Jan. 7-8, 2026. 4

In that release, D-Wave executive Murray Thom said the CES appearance “signals that the technology is quickly moving into the mainstream,” a message the company is expected to reprise as investors look for concrete customer traction. 4

Derivatives activity is also in focus. TheFly said options flow in QBTS was modestly bullish, with calls leading puts and 30-day implied volatility near 96 — options-market shorthand for expectations of bigger day-to-day swings. 2

TheFly estimated the implied volatility level translated into an expected daily move of about $1.55, a reminder that the stock can gap sharply even without a headline. 2

For investors new to the space, D-Wave markets “quantum annealing,” a quantum approach aimed at finding good solutions to complex optimization problems, and it also says it is developing gate-model systems, a more general-purpose quantum computing architecture. 4

Before the next major company update, traders are watching whether QBTS can hold recent support near the mid-$20s in thin year-end trading, and whether January events — CES Foundry and the Qubits 2026 user conference set for Jan. 27-28 in Florida, according to an SEC filing — generate new commercial detail. 5

Stock Market Today

Costco stock price retakes $1,000 — what traders are watching before Monday

Costco stock price retakes $1,000 — what traders are watching before Monday

7 February 2026
Costco closed Friday up 1.2% at $1,001.16, regaining the $1,000 level as about 2.36 million shares changed hands. January net sales rose 9.3% to $21.33 billion, with comparable sales up 7.1% and online sales surging 34.4%. Wells Fargo raised its price target to $950, maintaining a neutral rating. The next earnings call is set for March 5.
Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data

7 February 2026
Johnson & Johnson shares rose 0.9% to $239.99 Friday after a New Jersey appeals court disqualified Beasley Allen from state talc cases, citing improper coordination with a former J&J attorney. The ruling affects about 3,600 state lawsuits, while a related federal motion is pending. J&J also reported early 12-month pilot data for its investigational AFib device at a cardiology meeting.
Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today
Previous Story

Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today
Next Story

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

Go toTop